Pharmaceutical company supplying unlicensed drugs to critical need patients sees 44% leap in profits – This is Money


This is Money
Pharmaceutical company supplying unlicensed drugs to critical need patients sees 44% leap in profits
This is Money
A pharmaceutical company that links patients to drugs not yet been approved in the UK has revealed rising profits. Clinigen, which supplies unlicensed drugs to patients in critical need, said it had performed strongly in the first half of the year and

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd